Amplification of human polymorphic sites in the X-chromosomal region q21.33 to q24: DXS17, DXS87, DXS287, and alpha-galactosidase A.
Methods for the PCR amplification of five polymorphic sites in the region Xq21.33 to Xq24 were developed and used to predict heterozygosity for Fabry disease in informative families. Clones containing polymorphic sites associated with DNA segments DXS17, DXS87, and DXS287, and the alpha-galactosidase A gene were isolated from genomic libraries. Surrounding nucleotide sequences and optimal conditions for amplification of each polymorphic site were determined. These amplifiable polymorphisms provided predictions of heterozygosity for Fabry disease and should be useful for diagnostic linkage analyses in Alport syndrome, X-linked cleft palate and ankyloglossia, Pelizaeus-Merzbacher disease, and X-linked agammaglobulinemia as well as sequence-tagged sites for gene mapping.
Division of Medical and Molecular Genetics, Mount Sinai School of Medicine, New York, New York 10029.
R
R
Kornreich
K H
KH
Astrin
R J
RJ
Desnick
D001483:Base Sequence; D003001:Cloning, Molecular; D000795:Fabry Disease / Q000201:enzymology / Q000235:genetics*; D005260:Female; D015698:Genomic Library; D006579:Heterozygote; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D014960:X Chromosome; D000519:alpha-Galactosidase / Q000235:genetics*
D000519:alpha-Galactosidase